Clinical Trial: First-In-Human Study in Participants with Advanced Solid Tumors

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885645) titled 'First-In-Human Study in Participants with Advanced Solid Tumors' on March 06.

Brief Summary: A Phase 1 Study of KH815 for Injection to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity in Patients with Advanced Solid Tumors

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: KH815 for injection

KH815 for injection is a dual-payload Antibody Drug Conjugate (ADC) targeting TROP2 antigens.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chengdu Kanghong Biotech Co., Ltd.

Published by HT Digital Content Services with permission from H...